Life Science News

Latest updates from the biotech and pharma world

Endpoints News 2026-01-27

FDA lifts hold on one of two Phase 3 gene editing studies by Intellia

Endpoints News 2026-01-27

Insilico’s latest deal is a $120M cardiometabolic drug discovery pact with Qilu Pharma

Endpoints News 2026-01-27

AstraZeneca ends work on cardio drug; Lisata and Qilu terminate deal

Endpoints News 2026-01-27

Virtual women’s health company Wisp buys TBD Health

Endpoints News 2026-01-27

Boehringer Ingelheim gets an IBD bispecific from Shanghai-based Simcere

Endpoints News 2026-01-27

UK-US biotech investor Epidarex raises $145M for fourth fund

Endpoints News 2026-01-26

IRA drug pricing petitions pile up at the Supreme Court

Endpoints News 2026-01-26

Ex-CytoDyn CEO sentenced to 30 months for pump-and-dump scheme

Endpoints News 2026-01-26

Catalent plans to close Belgium cell therapy site

Endpoints News 2026-01-26

Sarepta touts three-year Duchenne gene therapy data after patient deaths

Endpoints News 2026-01-26

Genyro licences DNA builder from Caltech; Dizal targets Hong Kong listing

Endpoints News 2026-01-26

UK medicines agency seized 20M illegal drugs last year, including GLP-1s

Endpoints News 2026-01-26

Genmab halts enrollment for cancer drug from ProfoundBio buyout

Endpoints News 2026-01-24

First-movers respond to herding; BioMarin vets start new biotech; GSK buys RAPT Therapeutics; and more

Endpoints News 2026-01-23

Novo's Wegovy pill off to a solid start after just two weeks on market

Endpoints News 2026-01-23

EU kicks off one-year pilot to expedite multinational trials

Endpoints News 2026-01-23

ACIP members depict diverging goals after schedule change

Endpoints News 2026-01-23

F2G CEO outlines biotech's FDA resubmission plans, funding and expansion

Endpoints News 2026-01-23

Sanofi's Phase 3 eczema data cloud hopes for potential immunology blockbuster

Endpoints News 2026-01-23

Lilly was the only pharma bidder for Ventyx

-118 / 23